Synthetic Biologics Bullish Momentum

AMEX:SYN   Synthetic Biologics, Inc
Synthetic Biologics Announces Washington University School of Medicine in St. Louis IRB Approval of the SYN-004 (ribaxamase) Phase 1b/2a Clinical Protocol.
A previously completed placebo-controlled Phase 2b clinical trial of 412 patients demonstrated SYN-004 protected the gut microbiome from antibiotic-mediated dysbiosis. Patients receiving SYN-004 also demonstrated significantly better maintenance and recovery of the gut microbiome as well as lower incidences of new colonization by opportunistic and potentially pathogenic microorganisms such as VRE . (Source:

Please leave me a message if you want to test the buy and sell indicators that i am using.

Buy the indicator:

How to install the indicator after receiving the invite:


which algo do you use for those buy sell signals?
good DD, what's the indicator?